Rivista 11.26

Brivaracetam as Early Add-On Treatment in Patients with Focal Seizures: A Retrospective, Multicenter, Real-World Study.

Autori: Lattanzi S, Canafoglia L, Canevini MP, Casciato S, Cerulli Irelli E, Chiesa V, Dainese F, De Maria G, Didato G, Di Gennaro G, Falcicchio G, Fanella M, Ferlazzo E, Gangitano M, La Neve A, Mecarelli O, Montalenti E, Morano A, Piazza F, Pizzanelli C, Pulitano P, Ranzato F, Rosati E, Tassi L, Di Bonaventura C; BRIVAracetam add-on First Italian netwoRk Study (BRIVAFIRST) Group.

Data: 2022

Ambito di interesse: Epilessia

Rivista: Neurol Ther. 2022 Dec;11(4):1789-1804

Potrebbero interessarti anche:

Rivista 2.12

“Covid Solution”

Autori: Menicagli r

Data: 2020

Ambito di interesse: infettivologia

Rivista: International Journal of Preventive Medicine,

Leggi dettagli

Rivista 3,445

MiR-146a as marker of senescence-associated pro-inflammatory status in cells involved in vascular remodelling

Autori: Olivieri F, Lazzarini R, Recchioni R, Marcheselli F, Rippo MR, Di Nuzzo S, Albertini MC, Graciotti L, Babini L, Mariotti S, Spada G, Abbatecola AM, Antonicelli R, Franceschi C, Procopio AD

Data: 2013

Ambito di interesse: gerontologia, geriatria

Rivista: Age (Dordr).

Leggi dettagli

Rivista 21.566

Clinical and genetic study of a large SPG4 italian family with hereditary spastic paraplegia and early-onset familial Alzheimer’s disease

Autori: Lo Giudice T, Casella A, Mearini M, Montecchiani C, Miele M, Kawarai T, Orlacchio A.

Data: 2015

Ambito di interesse: Neurologia Alzheimer

Rivista: Alzheimer’s and dementia

Leggi dettagli

Brivaracetam as Early Add-On Treatment in Patients with Focal Seizures: A Retrospective, Multicenter, Real-World Study.

Potrebbero interessarti anche:

“Covid Solution”

MiR-146a as marker of senescence-associated pro-inflammatory status in cells involved in vascular remodelling

Clinical and genetic study of a large SPG4 italian family with hereditary spastic paraplegia and early-onset familial Alzheimer’s disease

Cosa fare per